With a current price of $133.41, HCA Healthcare Inc. [NYSE:HCA] is active in the Medical Care Facilities industry, with a 5-day price swing of 5.84%.
For the year, the stock is trading -10.81%, while, as a point of reference, the S&P 500 is trading 0.5% YTD. Other data to note on this name is a price per sales number of 0.87 and a price per cash flow number of 4.24.
Wait and see
Holding a Market Cap of $43.69 billion, HCA Healthcare Inc. has seen a trading range over the last year of $58.38-$151.97.
For the last five days, HCA is up from its last closing price. The average shares trading hands each day is 1.83M, with average 10-day volume coming in at 1.41 million.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for HCA. When we apply the Elder Force Index to HCA Healthcare Inc., we are seeing an Elder Force Indicator number of 1248947.34.
The recent performance of the stock is another area that can tell traders how to proceed. HCA is presenting an interesting case. This can be seen in the Forward P/E ratio, which currently stands at 11.42. Moreover, the company’s enterprise value has gone from $68.43B to $65.28B quarter-over-quarter. Obviously, the company is heading in the wrong direction, but there are still opportunities for growth in the sector.
In the last quarter, HCA made a profit of 9.32 billion. HCA Healthcare Inc. also saw quarter revenue growth year over year of 9.98%. In addition, the company has operating cash flow of $14.73 billion.
Looking at popular technical indicators, the company’s 5-day moving average is 130.90 compared to the 50-day moving average of 130.49. So, we are clearly seeing an upward trajectory here.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. HCA currently holds a 9-day RSI of 67.62%, while 100-day RSI stands at 52.70%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. HCA’s 9-day MACD is 4.10 and the company’s 100-day MACD stands at 13.41.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 21.78% by insiders and 72.31% by institutions. Regarding institutional holdings, Price (T.Rowe) Associates Inc owns 6.66%, while the second top holder, Vanguard Group, Inc. (The), currently owns 6.21%.
Over the last six months, insiders have sold 227 with the most recent transaction from Paslick P. Martin, SVP and CIO, with a sell at price 134.97 per share.
Overall, the recommended rating for HCA is Strong Buy. Currently, the company has 17 analysts watching the stock, and the average quarterly earnings estimate is 2.45. Quarterly revenue estimates are averaging 12.67B with the high estimate reaching 13.78B and the low at 11.87B.
To review, the current 1-year target estimate is sitting at 147.05, while the current price 133.41. Based on this, we expect the stock to rise considering the aforementioned fundamentals.